Org chart
Mark J. Gergen
Collapse
Kristin Martin
CHRO
Harry J. Leonhardt
General Counsel, CCO & Corporate Secretary
Brent Warner
President, Gene Therapy
Devon J. Shedlock
SVP, Research & Development
Johanna Mylet
SVP, Finance
Loren Wagner
SVP, Global Operations
Lisa Portale
SVP, Regulatory Affairs
Jeffrey W. Winkelman
VP, Intellectual Property
Karen Basbaum
VP, Business Development
Kristin Yarema
President, Cell Therapy
Carol Susla
Vice President Quality
